|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 45/06 | |||
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 2822588 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13708156.8 |
| Date of filing the European patent application | 2013-03-08 | |
| (97) | Date of publication of the European application | 2015-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/054676 |
| Date | 2013-03-08 |
| (87) | Number | WO 2013/132044 |
| Date | 2013-09-12 |
| (30) | Number | Date | Country code |
| 12158519 | 2012-03-08 | EP |
| (72) |
CANNARILE, Michael, DE
RIES, Carola, DE
RUETTINGER, Dominik, DE
WARTHA, Katharina, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF |